Search

BackgroundIndividuals with mild cognitive impairment and dementia have impaired physical and cognitive functions, leading to a reduced quality of life compared with those without such impairment. Exergaming, which is defined as a combination of exercise and gaming, is an innovative, fun, and relatively safe way to exercise in a virtual reality or gaming environment. Therefore, exergaming may help people living with mild cognitive impairment or dementia to overcome obstacles that they may experience regarding regular exercise and activities. ObjectiveThe aim of this systematic review was to review studies on exergaming interventions administered to elderly individuals with mild cognitive impairment and dementia, and to summarize the results related to physical and cognitive functions such as balance, gait, executive function, and episodic memory. MethodsWe searched Cochrane Central Register of Controlled Trials (CENTRAL), Medline, Embase, PsycINFO, Amed, and Nursing Database for articles published from the inception of the respective databases to January 2019. We included all clinical trials of exergaming interventions in individuals with mild cognitive impairment and dementia for review. The risk of bias was independently evaluated by two reviewers using the Cochrane Collaboration and Risk of Bias in Non-randomized Studies of Interventions tools. ResultsTen studies involving 702 participants were included for review. There was consistent evidence from 7 studies with a low risk of bias showing statistically significant effects of exergaming on cognitive functioning in people with mild cognitive impairment and dementia. With respect to physical function, 3 of 5 full-scale studies found positive results, and the intensity of most games was classified as moderate. ConclusionsOverall, exergaming is an innovative tool for improving physical and cognitive function in people with mild cognitive impairment or dementia, although there is high heterogeneity among studies in terms of the duration, frequency, and gaming platform used. The quality of the included articles was moderate to high. More high-quality studies with more accurate outcome indicators are needed for further exploration and validation of the benefits of exergaming for this population.

Cognitive dysfunction refers to the functional impairment in one or more cognitive domains, mostly occurs in older adults. Cognitive dysfunction can commonly be divided into subjective cognitive decline (SCD), mild cognitive impairment (MCI) and dementia, depending on the degree of cognitive impairment. People with SCD or MCI have a higher risk of dementia, which seriously affects their quality of life, and imposes a huge burden on families and society. Numerous studies have demonstrated that physical activity is one effective non-pharmacological intervention for cognitive dysfunction, but there are no uniform standards for physical activity programs for cognitive dysfunction worldwide, and China still has no physical activity guidelines based on the values and preferences of older adults with cognitive dysfunction, partially impeding the dissemination and application of relevant evidence. In view of this, we developed a guideline containing eight recommendations that is applicable in China, namely the Clinical Practice Guideline on Non-pharmacological Interventions for Older Adults with Cognitive Dysfunction: Physical Activity, by the use of existing evidence, and the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework combined with values and preferences of Chinese older adults with cognitive dysfunction. This guideline will contribute to the reduction of the incidence of cognitive dysfunction, and preventing or slowing the progression of cognitive dysfunction to dementia.

BACKGROUND Apatite is a common U-bearing accessory mineral with a U-Pb closure temperature of ~500℃, making U-Pb dating of apatite a potentially valuable thermochronometer. However, its low U concentration, high common lead concentration and lack of reference material has limited widespread application to LA-ICP-MS dating. OBJECTIVES To develop a technique for U-Pb dating of apatite using laser ablation sector field inductively coupled plasma-mass spectrometry (LA-HR-ICP-MS). METHODS The U-Pb isotope ratio in apatite samples was determined by LA-HR-ICP-MS, with apatite MAD2 as the external standard to correct U-Pb and Pb-Pb elemental fractionation directly without a common Pb correction. RESULTS Long-term U-Pb analysis of Madagascar apatite sample (MAD2) showed homogeneous distribution of U, Pb and U-Pb isotope ratios, with average contents of U and Pb ~23.8×10-6 and ~13.5×10-6, respectively and weighted average 207Pb/206Pb and 206Pb/238U ratios of 0.0941±0.0006 and 0.0794±0.0004, respectively. Taking MAD2 apatite as a reference mineral, combined with 207Pb-correction method, the ages of apatite samples, McClure Mountain (521±5Ma), Tory-Hill-apt (1021±16Ma), a Durango (30.7±1.5Ma) and Fagnshan diorite apatite (~131Ma) can be determined accurately. CONCLUSIONS The Madagascar apatite sample (MAD2) can be used to calibrate apatite U-Pb isotope ratio measured by LA-ICP-MS directly, without common-Pb correction, similar to the calibration strategy in zircon U-Pb dating. The method greatly reduces the difficulty of data processing during apatite U-Pb dating by LA-ICP-MS, which is conducive to the wide application of the method.

Rheumatoid arthritis (RA) is a common autoimmune disease characterized by progressive joint inflammation and destruction, deformity, loss of mobility, and permanent disability. Although the cellular and molecular mechanisms involved in RA are understood in detail, no drugs or therapies can completely cure RA. Many long-term efforts have been directed towards a better understanding of RA pathogenesis and the development of new classes of therapeutics. Thus, the ongoing elucidation of pathogenic events underlying RA mostly relies on studies of animalmodels. Herein, we comprehensively review and discuss the characteristics, challenges, and unresolved of issues of various experimental models of RA to provide a basis and reference for the rational selection of experimental RA models for basic investigations into traditional Chinese medicine (TCM).

The Alpinia katsumadai Hayata Doukou, DK, is a traditional Chinese medicine that has shown superior anti-inflammatory property, which is widely used in the food and commodity industry. A network pharmacology analysis was performed to identify the potential anti-acne compounds, hub therapeutic targets, and the key pathways via TCMSP, BATMAN, CTD, PDB and PubChem databases. Finally, the “compoundtarget- pathway” network was constructed. The study found total 7 active compounds, including quercetin, (2R)-5,7-dihydroxy-2-phenylchroman-4-one, dehydrodiisoeugenol, (2R)-7-hydroxy-5-methoxy-2- phenylchroman-4-one, Pinocembrin, and 1,7-diphenyl-5-hydroxy-6-hepten-3-one alpinolide peroxide. In addition, 30 therapeutic targets, and 4 hub therapeutic targets of the DK were identified. The biological processes were primarily related to inflammatory response, response to oxidative stress, regulation of insulin secretion, etc. Which was significantly associated with ten pathways including the PI3K-Akt signaling pathways, VEGF signaling pathways, etc. Furtherly, the 4 hub targets AKT1, F2, AR, and PTGS2 with higher connectivity in PPI network were verificated though molecular docking, which once again proved that these targets are potential targets of their corresponding chemical molecules. Therefore, DK might have a synergistic effect on the anti-inflammatory effects via the various active compositions, targets and signaling pathways.